Fexofenadine protects against lipopolysaccharide-induced acute lung injury by targeting cytosolic phospholipase A2

Chen, YH; Liu, H; Tian, YR; Luo, ZL; Ran, JJ; Miao, ZY; Zhang, QP; Yin, G; Xie, QB

Xie, QB (通讯作者),Sichuan Univ, West China Hosp, Dept Rheumatol & Immunol, 37 Guoxue lane, Chengdu 610041, Peoples R China.;Yin, G (通讯作者),Sichuan Univ, West China Hosp, Gen Practice Med Ctr, Dept Gen Practice, 37 Guoxue lane, Chengdu 610041, Peoples R China.

INTERNATIONAL IMMUNOPHARMACOLOGY, 2023; 116 ():

Abstract

Objective: Acute lung injury (ALI) causes acute respiratory distress syndrome, with a high mortality rate of 40%, with currently available pharmacolog......

Full Text Link